Eli Lilly (NYSE:LLY) stock is down 5% in Tuesday afternoon trading, with shares falling to $937 from a prior close of $989.12 ...

Eli Lilly (LLY) stock drops as HSBC downgrades the company warning that weight-loss drugmaker could be “priced to perfection.

Tim Coleman has held positions within information technology at Lilly in research and development, sales and marketing, ...

Shares of Eli Lilly came under pressure on Tuesday after HSBC downgraded the stock, raising fresh questions about whether the ...

Both Lilly and Viking are great buys today and could have bright futures in the weight loss drug market. Though Viking hasn't ...

An inside look at the 18-month secret recruitment that brought the pharmaceutical giant's largest state investment to the ...

The Lilly Technology Center investment includes expanding existing capabilities and the establishment of new production lines.